| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...
A research team led by Professor Leung Wai-keung from Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) and the Baylor College of ...
MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active ...
The helicobacter pylori (H. pylori) bacteria, a common bug that can cause stomach infections, developed a high resistance to key antibiotics in the two years since the pandemic started, a small new ...
A new clinical trial found consuming cranberry juice containing 44 mg of proanthocyanidins (or "PACs") per 240-mL serving twice daily for eight weeks resulted in a 20% reduction in the H. pylori ...
A history of Helicobacter pylori infection had a modest but statistically significant association with an increased risk of colorectal cancer (CRC), including fatal CRC, a large retrospective analysis ...
The researchers initially characterized the colonization of multiple H. pylori strains in control mice or mice with genetically induced tissue metaplasia. Several of the tested strains could infect ...
While conversations about cancer risk often center on genetics and lifestyle choices, emerging research highlights a more insidious threat lurking in millions of American stomachs. Helicobacter pylori ...
Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor, and ...
Dear Pharmacist: I took the stool test you recommended called “GI Effects” by Metametrix Labs, and it’s positive for high levels of a bacteria called H. Pylori. My doctor is treating me aggressively ...
Several Twitter users on Thursday, November 25, took to the micro-blogging site to narrate their experiences with bacteria Helicobacter pylori (H. Pylori). The users observed that H. Pylori seems to ...
The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results